SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Dana-Farber Cancer Institute at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

Dana-Farber Cancer Institute brings 32 presentations to SNO 2026 in Philadelphia. Its program covers survivorship, pathology, tumor biology and CNS lymphoma, along with plenary and rapid oral sessions. Research on synaptic diversity across brain tumors and on neurologic side effects of immunotherapy stands out.

OrganizationSNO 2026 Attendance
Hospitals & cancer centers
A cancer treatment and research center with clinical and laboratory programs in brain tumors and neuro-oncology.
Session
Fri Nov 13
8:30–10am
Plenary I
Exhibit Hall C, Second Floor, Convention Center
Session
Fri Nov 13
11:30am–12:30pm
Rapid Orals Session IV A
Exhibit Hall D & E, Second Floor, Convention Center
Talk
Fri Nov 13
11:30–11:33am
Patient, Care-Partner, and Clinician Perspectives on the Burden and Unmet Needs of Tumor-Related Aphasia: A Qualitative Study
Exhibit Hall D & E, Second Floor, Convention Center · Abstract QOL-09
Survivorship
Session
Fri Nov 13
12:45–2:15pm
Plenary II
Exhibit Hall C, Second Floor, Convention Center
Plenary
Fri Nov 13
12:45–2:15pm
Session
Fri Nov 13
5–6pm
Neurohematology Oral Abstracts Session
119 AB, First Floor, Convention Center
Lymphoma
Session
Fri Nov 13
5–6pm
Neurologic Complications of Antineoplastic Therapies
Terrace Ballroom I Convention Center
Survivorship
Talk
Fri Nov 13
5:21–5:28pm
Talk
Fri Nov 13
5:34–5:39pm
Poster
Fri Nov 13
7:30–9:30pm
Cell-state-specific proliferation and neuron-tumor communication in diffuse hemispheric gliomas with H3G34 Mutations
Exhibit Hall D & E, Second Floor, Convention Center · Abstract CNSC-61
Neuroscience
Poster
Fri Nov 13
7:30–9:30pm
Poster
Fri Nov 13
7:30–9:30pm
Poster
Fri Nov 13
7:30–9:30pm
Project HOPE: a longitudinal multidimensional profiling of high-grade gliomas in children, adolescents and young adults
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EPCO-23
Pathology
Poster
Fri Nov 13
7:30–9:30pm
Oncohistone, H3K27M, driven hypertranscription creates a therapeutic opportunity in diffuse midline gliomas
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-53
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
SOX4 is a dual regulator of stem cell-like transcriptional states and immune evasion in glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-13
Immunology
Poster
Fri Nov 13
7:30–9:30pm
Higher Levels of Emotional Distress is Associated with Poorer Survival in Patients with Glioblastoma on Immunotherapy
Exhibit Hall D & E, Second Floor, Convention Center · Abstract QOL-08
Survivorship
Poster
Fri Nov 13
7:30–9:30pm
Leveraging Genomic Alterations in Glioblastoma Multiforme
Exhibit Hall D & E, Second Floor, Convention Center · Abstract STEM-09
Tumor biology
Poster
Fri Nov 13
7:30–9:30pm
Exploiting metabolic dependencies to enhance PDGFRA inhibition in Diffuse Midline Glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMET-19
Tumor biology
Poster
Fri Nov 13
7:30–9:30pm
Spatial analysis of oncolytic virus-treated GBM reveals a novel hypoxic-specific immunosuppressive tumor cell mechanism
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMIC-61
Tumor biology
Session
Sat Nov 14
8:30–10am
Plenary III
Exhibit Hall C, Second Floor, Convention Center
Talk
Sat Nov 14
11:36–11:39am
Molecular subgroups and genomic clusters define distinct survival trajectories in IDH-wildtype glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract PATH-74
Pathology
Talk
Sat Nov 14
12–12:03pm
Radiation remodels the DMG cell state landscape by altering neuron-glioma interactions
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMIC-78
Tumor biology
Talk
Sat Nov 14
12:27–12:30pm
P300/CBP Inhibition Suppresses Stem-like Cell States in Histone-Altered Diffuse Midline Glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EPCO-36
Pathology
Session
Sat Nov 14
12:45–2:15pm
Plenary IV
Exhibit Hall C, Second Floor, Convention Center
Talk
Sat Nov 14
3:14–3:19pm
Talk
Sat Nov 14
5:44–5:49pm
Targeting of molecularly-defined ependymomas with trastuzumab deruxtecan
119 AB, First Floor, Convention Center · Abstract INNV-10
Survivorship · Rare tumors
Session
Sun Nov 15
9:45–10:45am
Pediatrics Oral Abstracts Session II
118 ABC, First Floor, Convention Center
Pediatrics
Talk
Sun Nov 15
10:22–10:27am
Multimodal characterization of brain invasion in pediatric gliomatosis cerebri: an international multicenter study
118 ABC, First Floor, Convention Center · Abstract PTHP-07
Pathology · Pediatrics
Talk
Sun Nov 15
11am–12pm

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Dana-Farber Cancer Institute

Tell us what you sell and we’ll find the people at Dana-Farber Cancer Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction